Skip to content

Study · Measured the body's own peptide · 2004

1 result

Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.

Höybye C

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society1 Feb 2004Cited by 66 (Europe PMC)

PMID14700552 (opens in a new tab)DOI10.1016/j.ghir.2003.09.003 (opens in a new tab)PepBankPUB-14700552
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In young adults with Prader-Willi syndrome, the body's own circulating oxytocin levels were abnormally low in relation to their obesity.

    In plain wordsIn young adults with Prader-Willi syndrome, the body's own oxytocin levels were lower than expected for their weight.

    Peptide
    Oxytocin
    Outcome
    DecreaseCirculating oxytocin level
    Study

    n: not reported in source

    Comparator
    Expected level in relation to obesity
    Outcome group
    Appetite and food intake · Endocrine and hormones

    Source sentences

    Summary
    In relation to the patients obesity circulating oxytocin levels were abnormally low and ghrelin levels abnormally high.
    1 context sentence
    Summary · context
    We examined a cohort of 19 young adults with clinical PWS (13 with positive genotype) and mean BMI of 35 kg/m2.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.